Asthma–COPD Overlap

A special issue of Medical Sciences (ISSN 2076-3271).

Deadline for manuscript submissions: closed (31 July 2020) | Viewed by 300

Special Issue Editors


E-Mail Website
Guest Editor
Pulmonary and Critical Care, COPD Medical Director at Deaconess Hospital, Evansville, Indiana; Adjunct Assistant professor at IU school of Med-Evansville, Indiana; Deaconess Hospital (Main campus and Gateway), Evansville, 600 Mary St, Evansville, IN 47710, USA
Interests: prevention of COPD readmission; six-minute walk test in chronic lung disease patients

E-Mail Website
Guest Editor
Medical Director, SLUCare Sleep Disorders Center, Professor of Internal Medicine, Adjunct Assistant Professor of Neurology, Associate Program Director, Sleep Medicine Fellowship, Division of Pulmonary, Critical Care, and Sleep Medicine, Saint Louis University School of Medicine, 1402 South Grand Blvd., MC / SLUH / 7 FDT, St. Louis, MO, USA
Interests: six-minute walk test in chronic lung disease patients continuous positive airway pressure (CPAP) for treatment of obstructive sleep apnea, as well as CPAP adherence

Special Issue Information

Dear Colleagues, 

Asthma is an inflammatory disease that affects the large and small airways with intermittent symptoms in the early disease and has a mechanism of bronchial hyperresponsiveness. Chronic obstructive pulmonary disease (COPD) is an irreversible inflammatory airway disease, one that affects the small airways in particular. Distinguishing between typical asthma and typical COPD is straightforward; however, when the symptoms overlap, then diagnosis and further treatment can be challenging. Hence, collectively, when you have a combination of clinical symptoms of reversible and irreversible airway disease, it is called asthma COPD overlap syndrome (ACOS), which is estimated to be present in 15% to 45% of the population with obstructive airway disease, and the prevalence increases with age. However, despite this presumed high prevalence, no significant review articles or prospective studies have been conducted to provide information on how to tackle the challenges of the conventional management of these patients.  

This Special Issue will collect ideas on how to diagnose and treat ACOS. It is important to study the mechanisms of each disease with their role of CD4 and CD8 interplay which leads to the formation of overlapping disease.

Research articles about detailed manifestations of ACOS disease are welcome. This includes but is not limited to:

  1. Review articles which can summarize the plan of diagnosis and treatment of already published material;
  2. Original research as prospective or retrospective views to analyze the mechanism of interplay and pathogenesis of ACOS;
  3. Panel discussion and communications about ACOS.

Dr. Raghav Gupta
Dr. Joseph Roland D. Espiritu
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medical Sciences is an international peer-reviewed open access quarterly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • Asthma
  • COPD
  • Airway disease
  • Inflammation

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop